B2B
Nuntius Therapeutics
London, United Kingdomwww.nuntiustx.com
Nuntius Therapeutics develops transformative mRNA therapies by leveraging proprietary delivery technology, machine learning and superior nucleic acid engineering. The company utilizes programmable, no
aliveseed
seed
Stage
2024
Founded
2
Funding Rounds
About
Nuntius Therapeutics develops transformative mRNA therapies by leveraging proprietary delivery technology, machine learning and superior nucleic acid engineering. The company utilizes programmable, non-immunogenic nanocarriers capable of superior tissue and cell targeting beyond the liver.
Explore Nuntius Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.